Taylor Patton was appointed as Chief Commercial and Marketing Officer at INTUITIVE SURGICAL INC.
“Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.”
INTUITIVE SURGICAL INC — fact timeline
Source-grounded facts extracted from INTUITIVE SURGICAL INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Henry L. Charlton changed role as Senior Vice President of Global Business Operations at INTUITIVE SURGICAL INC.
“Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.”
INTUITIVE SURGICAL INC shareholders approved Approval of amendment and restatement of Amended and Restated 2010 Incentive Award Plan.
“Proposal No. 4 : To approve the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan: For Against Abstain Broker Non-votes 260,005,547 22,129,032 1,056,767 29,960,297”
INTUITIVE SURGICAL INC shareholders approved Ratification of PricewaterhouseCoopers LLP as independent auditor at the 2026-12-31 meeting.
“Proposal No. 3 : To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain 308,789,950 4,067,630 294,063”
INTUITIVE SURGICAL INC shareholders approved Advisory vote on compensation of Named Executive Officers.
“Proposal No. 2 : To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement: For Against Abstain Broker Non-votes 265,030,878 17,018,702 1,141,766 29,960,297”
INTUITIVE SURGICAL INC shareholders approved Election of ten members to the Board.
“Proposal No. 1 : To elect ten members to the Board to serve until the 2027 Annual Meeting of Stockholders: Nominee For Against Abstain Broker Non-votes Craig H. Barratt, Ph.D. 273,151,253 9,610,497 429,596 29,960,297”
Craig H. Barratt was appointed as lead independent director at INTUITIVE SURGICAL INC.
“the independent directors of the Board appointed Craig H. Barratt, Ph.D., the Board’s current Chair, to serve as the lead independent director of the Board also effective July 1, 2025.”
Gary S. Guthart changed role as Executive Chair of the Board at INTUITIVE SURGICAL INC.
“Mr. Rosa will replace Gary S. Guthart, Ph.D., who will step down as Chief Executive Officer of the Company effective July 1, 2025 and will assume the position of Executive Chair of the Board as of that same date, and will continue to serve as a director.”
David J. Rosa was appointed as Chief Executive Officer at INTUITIVE SURGICAL INC.
“On May 14, 2025, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) appointed David J. Rosa, currently the Company’s President, as Chief Executive Officer of the Company effective July 1, 2025.”
Henry L. Charlton changed role as Executive Vice President, Chief Commercial and Marketing Officer at INTUITIVE SURGICAL INC.
“In addition, effective January 1, 2025, Henry L. Charlton was promoted to serve as Executive Vice President, Chief Commercial and Marketing Officer of the Company.”
Jamie E. Samath changed role as Executive Vice President, Chief Financial Officer and Head of Business Technology at INTUITIVE SURGICAL INC.
“Effective January 1, 2025, Jamie E. Samath was promoted to serve as Executive Vice President, Chief Financial Officer and Head of Business Technology of Intuitive Surgical, Inc. (the “Company”).”
David J. Rosa was appointed as Director at INTUITIVE SURGICAL INC.
“On July 24, 2024, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) appointed David J. Rosa to the Board effective as of July 24, 2024.”
INTUITIVE SURGICAL INC shareholders rejected To consider and vote upon a stockholder proposal requesting a racial and gender pay gap report.
“Proposal No. 6 : To consider and vote upon a stockholder proposal requesting a racial and gender pay gap report: For Against Abstain Broker Non-votes 94,805,903 191,660,557 1,858,948 27,308,327”
INTUITIVE SURGICAL INC shareholders approved To approve the amendment and restatement of the Company’s Amended and Restated 2000 Employee Stock Purchase Plan.
“Proposal No. 5 : To approve the amendment and restatement of the Company’s Amended and Restated 2000 Employee Stock Purchase Plan: For Against Abstain Broker Non-votes 286,625,794 1,238,852 460,762 27,308,327”
INTUITIVE SURGICAL INC shareholders approved To approve the amendment and restatement of the Company’s Amended and Restated 2010 Plan.
“Proposal No. 4 : To approve the amendment and restatement of the Company’s Amended and Restated 2010 Plan: For Against Abstain Broker Non-votes 256,685,860 30,150,286 1,489,262 27,308,327”
INTUITIVE SURGICAL INC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-12-31 meeting.
“Proposal No. 3 : To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024: For Against Abstain 313,018,376 1,740,078 875,281”
INTUITIVE SURGICAL INC shareholders approved To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement.
“Proposal No. 2 : To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement: For Against Abstain Broker Non-votes 269,468,985 17,718,629 1,137,794 27,308,327”
INTUITIVE SURGICAL INC shareholders approved To elect eleven members to the Board to serve a one-year term expiring at the 2025 Annual Meeting of Stockholders.
“Proposal No. 1 : To elect eleven members to the Board to serve a one-year term expiring at the 2025 Annual Meeting of Stockholders: Nominee For Against Abstain Broker Non-votes Craig H. Barratt, Ph.D. 279,379,048 8,598,876 347,484 27,308,327 Joseph C. Beery 287,030,358 932,653 362,397 27,308,327 Lewis Chew 285,273,383 2,682,213 369,812 27,308,327 Gary S. Guthart, Ph.D. 286,871,239 1,103,400 350,769 27,308,327 Amal M. Johnson 273,231,380 14,723,004 371,024 27,308,327 Sreelakshmi Kolli 268,491,109 19,454,661 379,638 27,308,327 Amy L. Ladd, M.D. 284,914,158 3,055,772 355,478 27,308,327 Keith R. Leonard, Jr. 286,896,093 1,058,794 370,521 27,308,327 Jami Dover Nachtsheim 282,893,287 5,063,491 368,630 27,308,327 Monica P. Reed, M.D. 284,862,203 3,113,441 349,764 27,308,327 Mark J. Rubash 273,769,838 13,465,191 1,090,379 27,308,327”
Alan J. Levy departed as Director at INTUITIVE SURGICAL INC.
“Alan J. Levy, Ph.D., who did not stand for re-election at the Annual Meeting”
Lewis Chew was appointed as Director and Chair of the Audit Committee at INTUITIVE SURGICAL INC.
“On April 25, 2024, the Board of Directors (the “Board”) appointed Lewis Chew to succeed Mark J. Rubash as Chair of the Audit Committee.”
INTUITIVE SURGICAL INC reported the quarter ended March 31, 2024 results: revenue $1.89 billion, net income $545 million, EPS $1.51 per diluted share.
“First quarter 2024 revenue of $1.89 billion increased 11% compared with $1.70 billion in the first quarter of 2023.”
INTUITIVE SURGICAL INC reported the quarter ended December 31, 2023 results: revenue $1.93 billion, net income $606 million, or $1.69 per diluted share, EPS $1.69 per diluted share.
“installed base to 8,606 systems as of December 31, 2023, an increase of 14% compared with 7,544 as of the end of the fourth quarter of 2022. • Fourth quarter 2023 revenue of $1.93 billion increased 17% compared with $1.66 billion in the fourth quarter of 2022. • Fourth quarter 2023 GAAP net income attributable to Intuitive was $606 million, or $1.69 per diluted”
INTUITIVE SURGICAL INC reported the fourth quarter and full year 2023 results: revenue approximately $1.93 billion. Guidance reaffirmed.
“The Company placed 1,370 da Vinci surgical systems in 2023, an increase of 8% compared with 1,264 systems in 2022. • Preliminary fourth quarter 2023 revenue of approximately $1.93 billion increased 17% compared with $1.66 billion in the fourth quarter of 2022. Preliminary 2023 revenue of approximately $7.12 billion increased 14% compared with $6.22 billion in”
Sreelakshmi Kolli was appointed as Director at INTUITIVE SURGICAL INC.
“appointed Sreelakshmi Kolli to the Board effective as of October 27, 2023.”
INTUITIVE SURGICAL INC reported the quarter ended September 30, 2023 results: revenue $1.74 billion, net income $416 million, or $1.16 per diluted share, EPS $1.16 per diluted share.
“installed base to 8,285 systems as of September 30, 2023, an increase of 13% compared with 7,364 as of the end of the third quarter of 2022. • Third quarter 2023 revenue of $1.74 billion increased 12% compared with $1.56 billion in the third quarter of 2022. • Third quarter 2023 GAAP net income attributable to Intuitive was $416 million, or $1.16 per diluted”
INTUITIVE SURGICAL INC reported the quarter ended June 30, 2023 results: revenue $1.76 billion, net income $421 million, EPS $1.18 per diluted share.
“• Second quarter 2023 revenue of $1.76 billion increased 15% compared with $1.52 billion in the second quarter of 2022. • Second quarter 2023 GAAP net income attributable to Intuitive was $421 million, or $1.18 per diluted share, compared with $308 million, or $0.85 per diluted share, in the second quarter of 2022.”
Gary S. Guthart changed role as President at INTUITIVE SURGICAL INC.
“Gary S. Guthart, Ph.D., will cease to hold the title of President and will continue to serve as the Company’s Chief Executive Officer and as a member of its Board of Directors.”
David J. Rosa changed role as President at INTUITIVE SURGICAL INC.
“On May 15, 2023, the Board of Directors of Intuitive Surgical, Inc. (the “Company” or “Intuitive”) promoted David J. Rosa to the role of President of the Company, effective May 16, 2023.”
INTUITIVE SURGICAL INC shareholders rejected To consider and vote upon a stockholder proposal regarding pay equity disclosure.
“Proposal No. 5 : To consider and vote upon a stockholder proposal regarding pay equity disclosure: For Against Abstain Broker Non-votes 98,764,665 180,992,684 3,935,502 25,189,301 Proposal No. 5 was rejected.”
INTUITIVE SURGICAL INC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-12-31 meeting.
“Proposal No. 4 : To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstain 306,654,434 1,157,337 1,070,381 Proposal No. 4 was approved.”
INTUITIVE SURGICAL INC shareholders approved To consider and approve, on an advisory basis, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
“Proposal No. 3 : To consider and approve, on an advisory basis, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement: 1 Year 2 Years 3 Years Abstain Broker Non-votes 280,214,412 229,749 2,745,574 503,116 25,189,301 The annual frequency was approved on an advisory basis.”
INTUITIVE SURGICAL INC shareholders approved To consider and approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
“Proposal No. 2 : To consider and approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement: For Against Abstain Broker Non-votes 256,335,720 23,958,341 3,398,790 25,189,301 Proposal No. 2 was approved on an advisory basis.”
INTUITIVE SURGICAL INC shareholders approved To elect eleven members to the Board to serve a one-year term expiring at the 2024 Annual Meeting of Stockholders.
“Proposal No. 1 : To elect eleven members to the Board to serve a one-year term expiring at the 2024 Annual Meeting of Stockholders:”
INTUITIVE SURGICAL INC reported the quarter ended December 31, 2022 results: revenue $1.66 billion, net income $325 million, EPS $0.91 per diluted share.
“• Fourth quarter 2022 revenue of $1.66 billion increased 7% compared with $1.55 billion in the fourth quarter of 2021. • Fourth quarter 2022 GAAP net income attributable to Intuitive was $325 million, or $0.91 per diluted share, compared with $381 million, or $1.04 per diluted share, in the fourth quarter of 2021.”
INTUITIVE SURGICAL INC reported fourth quarter and full year 2022 results: revenue approximately $1.66 billion. Guidance reaffirmed.
“Preliminary fourth quarter 2022 revenue of approximately $1.66 billion increased 7% compared with $1.55 billion in the fourth quarter of 2021. Preliminary 2022 revenue of approximately $6.22 billion increased 9% compared with $5.71 billion in 2021.”
Fredrik Widman was appointed as Principal Accounting Officer at INTUITIVE SURGICAL INC.
“Fredrik Widman will serve as the Company’s Principal Accounting Officer, effective January 1, 2022.”
Jamie Samath was appointed as Chief Financial Officer at INTUITIVE SURGICAL INC.
“appointed Jamie Samath as Chief Financial Officer, effective as of January 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.